Cyclooxygenase Inhibitors in Epithelial Ovarian Cancer Treatment
Cyclooxygenase Inhibitors in Epithelial Ovarian Cancer Treatment
About this item
Full title
Author / Creator
Publisher
United States: by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology
Journal title
Language
English
Formats
Publication information
Publisher
United States: by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology
Subjects
More information
Scope and Contents
Contents
AbstractEpithelial ovarian cancer (EOC) is the fifth most common cause of cancer mortality among women. At present, EOC is treated with one or in a combination of treatments, commonly debulking surgery, combining a platinum-based and a taxane-based therapy; however, the patients have a risk of injury to the bowel, bladder, ureter, and vessels durin...
Alternative Titles
Full title
Cyclooxygenase Inhibitors in Epithelial Ovarian Cancer Treatment
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2035245025
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2035245025
Other Identifiers
ISSN
1048-891X,1525-1438
E-ISSN
1525-1438
DOI
10.1097/IGC.0000000000001269
